| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |